RxDoctor Payments Data

Sarah Lang, MD

Family Medicine · Streetsboro, OHNPI 1346315116

Payments from drug & device makers

$3,800in general payments, 2019–2025

Across 42 payments — averaging $90.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$3K
  • Novo Nordisk$160
  • AstraZeneca$101
  • AbbVie$92
  • Exact Sciences$79
  • Corcept Therapeutics$53
  • plus $157 from 7 others

What the payments were for

  • Consulting fees$2,29660%
  • Travel & lodging$73719%
  • Food & beverage$76720%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen7$3,158
Novo Nordisk10$160
AstraZeneca6$101
AbbVie4$92
Exact Sciences4$79
Corcept Therapeutics2$53
Abbott2$42
Lilly USA, LLC2$34
Novartis1$22
GSK1$19
Boehringer Ingelheim1$14
E.r. Squibb & Sons, L.L.C.1$13
Alfasigma USA, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,800 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$23,634
Medicare patients
97
Services billed
537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin121$135,019
MounjaroTirzepatide53$79,381
EliquisApixaban65$63,072
FarxigaDapagliflozin Propanediol58$56,030
OzempicSemaglutide49$55,690
JanuviaSitagliptin Phosphate30$37,941
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$22,567
Repatha SureclickEvolocumab18$19,473
XareltoRivaroxaban14$14,340
TrulicityDulaglutide11$11,812
JanumetSitagliptin Phos/Metformin Hcl11$9,607
Atorvastatin Calcium379$3,534
Aripiprazole14$2,596
Bupropion XlBupropion Hcl42$2,229
Rosuvastatin Calcium111$2,111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$14$135,019121 claims
Lilly USA, LLCMounjaro, Trulicity$34$91,19264 claims
AstraZenecaFarxiga$101$56,03058 claims
Novo NordiskOzempic$160$55,69049 claims
GSKTrelegy Ellipta$19$22,56728 claims
AbbVieSynthroid$92$1,16432 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Streetsboro

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →